HongShan

Sign up free to access full profile and submit your pitch.

About

HongShan, formerly known as Sequoia China Investment Management LLP, is a private equity and venture capital firm specializing in angel, seed stage, start-up, early stage, mid stage, late stage, growth stage, emerging growth, expansion stage, buyout, mergers and acquisitions investments. It primarily invests in the field of new infrastructure, technology/media, telecommunications, internet, hard and core technology, science and technology innovation, advanced technology, fintech, new energy, new materials, technology finance, enterprise services, medical healthcare, new drugs, new diagnostic techniques, big health, ophthalmology, consumer products/consumer services, fashion consumption of overseas brands, new forms of trade, consumer upgrade, logistics, supply chain, advanced manufacturing, robots, extended reality chips, industrial technology, big data, carbon neutrality, changes brought about by artificial intelligence technology on new drug development, and biomedical innovation with focus on gene therapy, gene sequencing, and gene editing. It seeks to invest in recreational, cultural and sports consumption. The firm typically invests in specialized, refined, special, and innovative enterprises. It makes ESG investments. The firm is also engaged in public market investments. It typically invests between $0.10 million and $50 million in a company. The firm prefers to invest in the primary and secondary markets. It seeks to invest in China. HongShan was founded in September 2005 and is based in Beijing, China with additional offices in Admiralty, Hong Kong; Shanghai, China; Bengaluru, Shenzhen, China, Tokyo, Japan & New Delhi, India; Singapore; Tel-Aviv, Israel; London, United Kingdom and Menlo Park, California. HongShan operates as a subsidiary of Sequoia Capital Operations LLC.

Investment Criteria